ArticleClinical and vaccine immunology : CVI2013

Evaluation of RevA, a fibronectin-binding protein of Borrelia burgdorferi, as a potential vaccine candidate for lyme disease.

Angela M Floden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.